Squamous cell carcinoma (SCC) of the Pyriform sinus with multiple metachronous brain metastases, a case report

[1] Gouw ZAR(2017)A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response Clin Transl Radiat Oncol 6 1-6

[2] Jasperse B(2001)Intracranial metastases in patients with squamous cell carcinoma of the head and neck Otolaryngol Head Neck Surg 124 217-221

[3] Sonke JJ(1996)Metastatic hypopharyngeal carcinoma to the temporal bone Eur Arch Otorhinolaryngol 253 185-188

[4] de Bree R(2002)Metastatic head and neck squamous cell carcinoma to the brain Auris Nasus Larynx 29 47-54

[5] Mehta DM(2018)A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer Anticancer Research 38 4199-4202

[6] Snow GB(2009)Cancer of the tonsil presenting as central nervous system metastasis: A case report Head & Neck 31 127-130

[7] Quak JJ(2017)Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial Lancet Oncol 18 1049-1060

[8] Nakamura M(2019)Efficacy and Tolerance of Post – operative Hypo - Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases Front Oncol 9 184-141

[9] Kaga K(2011)Adjuvant whole – brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study J Clin Oncol 29 134-1489

[10] Ohira Y(1998)Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial JAMA 280 1485-undefined

[1] Gouw ZAR(2017)A predictive model for residual disease after (chemo) radiotherapy in oropharyngeal carcinoma: Combined radiological and clinical evaluation of tumor response Clin Transl Radiat Oncol 6 1-6

[2] Jasperse B(2001)Intracranial metastases in patients with squamous cell carcinoma of the head and neck Otolaryngol Head Neck Surg 124 217-221

[3] Sonke JJ(1996)Metastatic hypopharyngeal carcinoma to the temporal bone Eur Arch Otorhinolaryngol 253 185-188

[4] de Bree R(2002)Metastatic head and neck squamous cell carcinoma to the brain Auris Nasus Larynx 29 47-54

[5] Mehta DM(2018)A Tool to Predict the Probability of Intracerebral Recurrence or New Cerebral Metastases After Whole-brain Irradiation in Patients with Head-and-Neck Cancer Anticancer Research 38 4199-4202

[6] Snow GB(2009)Cancer of the tonsil presenting as central nervous system metastasis: A case report Head & Neck 31 127-130

[7] Quak JJ(2017)Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial Lancet Oncol 18 1049-1060

[8] Nakamura M(2019)Efficacy and Tolerance of Post – operative Hypo - Fractionated Stereotactic Radiotherapy in a Large Series of Patients With Brain Metastases Front Oncol 9 184-141

[9] Kaga K(2011)Adjuvant whole – brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study J Clin Oncol 29 134-1489

[10] Ohira Y(1998)Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial JAMA 280 1485-undefined